Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Titan Pharmaceuticals Inc TTNP

Healthcare
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The... see more

Recent & Breaking News (NDAQ:TTNP)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, TTNP on Behalf of Shareholders

PR Newswire September 9, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, CFB, TTNP, DFS on Behalf of Shareholders

Accesswire September 5, 2024

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP

PR Newswire September 4, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPXX, PWUP, DECA, TTNP on Behalf of Shareholders

PR Newswire September 4, 2024

STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers of ITI, TTNP and FRZA

Accesswire September 3, 2024

Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders

PR Newswire August 23, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders

Accesswire August 22, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Titan Pharmaceuticals, Inc. Merger

Newsfile August 22, 2024

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

Business Wire August 22, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, MCRB, LLAP on Behalf of Shareholders

PR Newswire August 20, 2024

TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders

Business Wire August 19, 2024

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

GlobeNewswire August 19, 2024

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

GlobeNewswire January 25, 2024

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

GlobeNewswire December 28, 2023

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

GlobeNewswire October 16, 2023

Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock

GlobeNewswire September 18, 2023

Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

GlobeNewswire July 27, 2023

Titan Pharmaceuticals Provides Shareholder Update

GlobeNewswire December 15, 2022

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

GlobeNewswire December 12, 2022

Titan Pharmaceuticals Announces Board Expansion and Management Changes

PR Newswire August 16, 2022